Literature DB >> 33721266

A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation.

Saki Hayashi1, Naro Ohashi2, Daiki Goto1, Naomi Isomura3, Shinsuke Isobe1, Tomoyuki Fujikura1, Yoshihide Fujigaki4, Akira Shimizu5, Hiroaki Ito3, Hideo Yasuda1.   

Abstract

Preeclampsia and superimposed preeclampsia usually develop after 20 weeks of gestation. We report a case of a 35-year-old Japanese woman who developed hypertensive disorders of pregnancy (HDP) before 20 weeks of gestation. She presented with hypertension and proteinuria at 9 and 11 weeks of gestation, respectively, and developed nephrotic syndrome at 17 weeks of gestation. She did not have definite hypertension or urinary abnormalities before pregnancy. The patient was serologically positive for the antinuclear antibody. However, the complement levels were normal and anti-phospholipid antibody was not detected. A renal biopsy performed at 18 weeks of gestation showed diffuse endotheliosis and tip lesions of secondary focal segmental glomerulosclerosis but no hypertensive changes of the arterioles. Although electron microscopic examination showed electron-dense deposits in the subendothelial lesions, they were considered nonspecific plasma exudation by mass spectrometry. An abortion was performed at 20 weeks gestation because the patient's congestive symptoms due to nephrotic syndrome had worsened and marked fetal growth restriction was observed. After delivery, the patient's symptoms resolved immediately without any additional treatment; however, continuous antihypertensive medication was required. Finally, the patient was diagnosed with HDP based on the renal biopsy findings and her clinical course after delivery. Compared to previous reports, this case describes the earliest onset of HDP. Thus, HDP should be considered as a differential diagnosis in pregnant women with hypertension or proteinuria presenting with symptoms before 20 weeks of gestation.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  20 weeks of gestation; Early onset; Hypertensive disorders of pregnancy; Preeclampsia

Mesh:

Year:  2021        PMID: 33721266      PMCID: PMC8494829          DOI: 10.1007/s13730-021-00592-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  25 in total

1.  Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.

Authors:  Arsène Mekinian; Marie-Charlotte Bourrienne; Lionel Carbillon; Amélie Benbara; Abisror Noémie; Sylvie Chollet-Martin; Ahmed Tigaizin; Francois Montestruc; Olivier Fain; Pascale Nicaise-Roland
Journal:  Semin Arthritis Rheum       Date:  2016-05-25       Impact factor: 5.532

Review 2.  Preeclampsia: A close look at renal dysfunction.

Authors:  Hakimeh Moghaddas Sani; Sepideh Zununi Vahed; Mohammadreza Ardalan
Journal:  Biomed Pharmacother       Date:  2018-11-03       Impact factor: 6.529

Review 3.  Hypertension in pregnancy.

Authors:  M S Paller
Journal:  J Am Soc Nephrol       Date:  1998-02       Impact factor: 10.121

4.  Preeclampsia before 20 weeks of gestation: a case report and review of the literature.

Authors:  Mari Tanaka; Yasushi Tsujimoto; Kimihiko Goto; Kana Kumahara; Saeko Onishi; Sachio Iwanari; Daiki Fumihara; Syo Miki; Masaki Ikeda; Kanae Sato; Hiroshi Sato; Masaya Hirose; Hiroya Takeoka
Journal:  CEN Case Rep       Date:  2014-08-09

5.  Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Authors:  Fadi Fakhouri; Lubka Roumenina; François Provot; Marion Sallée; Sophie Caillard; Lionel Couzi; Marie Essig; David Ribes; Marie-Agnès Dragon-Durey; Frank Bridoux; Eric Rondeau; Veronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

Review 6.  Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.

Authors:  Joy Liu; Tara T Ghaziani; Jacqueline L Wolf
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

7.  Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.

Authors:  Ravi Thadhani; Henning Hagmann; Wiebke Schaarschmidt; Bernhard Roth; Tuelay Cingoez; S Ananth Karumanchi; Julia Wenger; Kathryn J Lucchesi; Hector Tamez; Tom Lindner; Alexander Fridman; Ulrich Thome; Angela Kribs; Marco Danner; Stefanie Hamacher; Peter Mallmann; Holger Stepan; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2015-09-24       Impact factor: 10.121

8.  Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

Authors:  Harald Zeisler; Elisa Llurba; Frederic Chantraine; Manu Vatish; Anne Cathrine Staff; Maria Sennström; Matts Olovsson; Shaun P Brennecke; Holger Stepan; Deirdre Allegranza; Peter Dilba; Maria Schoedl; Martin Hund; Stefan Verlohren
Journal:  N Engl J Med       Date:  2016-01-07       Impact factor: 91.245

9.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.